(Q27853381)

3

object named as

E Papaemmanuil

0 references

author name string

V I Gaidzik

1

0 references

V Teleanu

2

0 references

D Weber

4

0 references

P Paschka

5

0 references

J Hahn

6

0 references

T Wallrabenstein

7

0 references

B Kolbinger

8

0 references

C H Köhne

9

0 references

H A Horst

10

0 references

P Brossart

11

0 references

G Held

12

0 references

A Kündgen

13

0 references

M Ringhoffer

14

0 references

K Götze

15

0 references

M Rummel

16

0 references

P Campbell

18

0 references

J M Kraus

19

0 references

H A Kestler

20

0 references

F Thol

21

0 references

M Heuser

22

0 references

B Schlegelberger

23

0 references

A Ganser

24

0 references

L Bullinger

25

0 references

R F Schlenk

26

0 references

K Döhner

27

0 references

H Döhner

28

0 references

publication date

November 2016

0 references

published in

Leukemia

0 references

volume

30

0 references

issue

11

0 references

page(s)

2160-2168

0 references

cites work

Acute Myeloid Leukemia

1 reference

https://api.crossref.org/works/10.1038/LEU.2016.126

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LEU.2016.126

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LEU.2016.126

AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LEU.2016.126

RUNX1 mutations in acute myeloid leukemia: results from a comprehensive genetic and clinical analysis from the AML study group

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LEU.2016.126

RUNX1 mutations are associated with poor outcome in younger and older patients with cytogenetically normal acute myeloid leukemia and with distinct gene and MicroRNA expression signatures

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LEU.2016.126

Post-remission therapy for acute myeloid leukemia

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LEU.2016.126

Valproic acid in combination with all-trans retinoic acid and intensive therapy for acute myeloid leukemia in older patients

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LEU.2016.126

Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LEU.2016.126

Clinical impact of DNMT3A mutations in younger adult patients with acute myeloid leukemia: results of the AML Study Group (AMLSG).

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LEU.2016.126

Nonparametric Estimation from Incomplete Observations

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/LEU.2016.126

Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.126

Translational implications of somatic genomics in acute myeloid leukaemia.

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.126

How I treat the older patient with acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.126

AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.126

RUNX1 mutations in clonal myeloid disorders: from conventional cytogenetics to next generation sequencing, a story 40 years in the making

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.126

Impaired hematopoietic differentiation of RUNX1-mutated induced pluripotent stem cells derived from FPD/AML patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.126

Genome profiling of chronic myelomonocytic leukemia: frequent alterations of RAS and RUNX1 genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.126

AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: prognostic implication and interaction with other gene alterations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.126

Clinical effect of point mutations in myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.126

RUNX1 mutations in cytogenetically normal acute myeloid leukemia are associated with a poor prognosis and up-regulation of lymphoid genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.126

Clinical and biological implications of driver mutations in myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.126

Landscape of genetic lesions in 944 patients with myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.126

Prognostic relevance of RUNX1 mutations in T-cell acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.126

Mutations of AML1 are common in therapy-related myelodysplasia following therapy with alkylating agents and are significantly associated with deletion or loss of chromosome arm 7q and with subsequent leukemic transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.126

Cooperativity of RUNX1 and CSF3R mutations in severe congenital neutropenia: a unique pathway in myeloid leukemogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.126

High frequency of RUNX1 biallelic alteration in acute myeloid leukemia secondary to familial platelet disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.126

Recognizing familial myeloid leukemia in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.126

Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.126

IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.126

ASXL1 mutations in younger adult patients with acute myeloid leukemia: a study by the German-Austrian Acute Myeloid Leukemia Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.126

The prevention and treatment of missing data in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.126

Acute myeloid leukemia in the real world: why population-based registries are needed

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.126

Genetic alterations of the cohesin complex genes in myeloid malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2016.126

Somatic point mutations in RUNX1/CBFA2/AML1 are common in high-risk myelodysplastic syndrome, but not in myelofibrosis with myeloid metaplasia

21 January 2018

1 reference

12 December 2020

RUNX1 gene mutation in primary myelodysplastic syndrome--the mutation can be detected early at diagnosis or acquired during disease progression and is associated with poor outcome

1 reference

12 December 2020

Censoring distributions as a measure of follow-up in survival analysis

1 reference

12 December 2020

Impact of genetic features on treatment decisions in AML.

1 reference

12 December 2020

Novel RUNX1 mutations in familial platelet disorder with enhanced risk for acute myeloid leukemia: clues for improved identification of the FPD/AML syndrome

1 reference

12 December 2020

Insights into familial platelet disorder with propensity to myeloid malignancy (FPD/AML)

1 reference

12 December 2020

RUNX1 mutations are frequent in de novo AML with noncomplex karyotype and confer an unfavorable prognosis

1 reference

12 December 2020

Mutation analysis for RUNX1, MLL-PTD, FLT3-ITD, NPM1 and NRAS in 269 patients with MDS or secondary AML

1 reference

12 December 2020

Prospective evaluation of allogeneic hematopoietic stem-cell transplantation from matched related and matched unrelated donors in younger adults with high-risk acute myeloid leukemia: German-Austrian trial AMLHD98A

1 reference

12 December 2020

High incidence of biallelic point mutations in the Runt domain of the AML1/PEBP2 alpha B gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired trisomy 21

1 reference

12 December 2020

Implications of somatic mutations in the AML1 gene in radiation-associated and therapy-related myelodysplastic syndrome/acute myeloid leukemia

1 reference

12 December 2020

Mutations of the AML1 gene in myelodysplastic syndrome and their functional implications in leukemogenesis

1 reference

12 December 2020

Biallelic and heterozygous point mutations in the runt domain of the AML1/PEBP2alphaB gene associated with myeloblastic leukemias

1 reference

12 December 2020

Trisomy 13 is strongly associated with AML1/RUNX1 mutations and increased FLT3 expression in acute myeloid leukemia

1 reference

12 December 2020

Myelodysplasia and leukemia of Fanconi anemia are associated with a specific pattern of genomic abnormalities that includes cryptic RUNX1/AML1 lesions

1 reference

12 December 2020

Identifiers

DOI

10.1038/LEU.2016.126

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

4824249

Dimensions Publication ID

1043572977

0 references

OpenCitations bibliographic resource ID

4824249

1 reference